Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Trinity Biotech Reports CE Marking Of Rapid Test For Giardia - Quick Facts

Trinity Biotech plc (TRIB: Quote) said it had obtained CE Marking and has filed for FDA approval for its new point-of-care Uni-GoldTM Giardia Test. Giardiasis is caused by an enteric parasite, Giardia lamblia, that infects the colon of humans and animals. The Trinity Biotech Uni-GoldTM Giardia Test has been designed as a rapid lateral flow immunoassay to detect the presence of Giardia lamblia antigen in fresh and preserved human stool specimens.

Also, Trinity Biotech added that CE marking allows this product to be sold in European markets and the company would immediately begin selling this product via. its extensive distributor network in Europe and other territories. In the mean time, the company has filed for FDA approval in the USA and this is expected to be granted in the first half of 2012.

The product was developed by a dedicated research team at Trinity'sSan Diego facility and is the first of a new range of point-of-care tests to be developed. When this product is combined with its forthcoming tests for Cryptosporidium and C Difficile, Trinity would then have a full enteric panel, all of which would be CE marked by June 2012 and approved for sale in the USA by the third quarter end.

Register
To receive FREE breaking news email alerts for Trinity Biotech plc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Home improvement and building products company Masco Corp. said Monday after the markets closed that its second quarter profit jumped 78% from last year, as revenue increased and margins improved amid strong performance of its Plumbing Products, Installation and Other Services and Decorative Architectural Products segments. American Financial Group Inc. (AFG) Monday reported second-quarter net earnings of $106 million or $1.15 per share, compared to $110 million or $1.20 per share last year. Core net operating earnings were $99 million or $1.07 per share, compared to $87 million or $0.96 per share last year. Total... Stocks showed a significant recovery over the course of the trading day on Monday after coming under pressure in early trading. The markets eventually ended the session roughly flat following the mixed performance that was seen last week.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.